Table 1.
Characteristics of the study group.
| Controls (n = 11) | CVID (n = 26) | P-value | |
|---|---|---|---|
| Demographics | |||
| Gender (male/female, %) | 45/55 | 50/50 | 0·8 |
| Age (years, median and 25th −75th percentiles) | 45 (38–65) | 49 (39–58) | 0·92 |
| Clinical characteristics | |||
| Bronchiectasis (%) | 69 | ||
| Splenomegaly (%) | 58 | ||
| Idiopathic thrombocytopenic purpura (%)* | 34 | ||
| Granulomatous disease (%)** | 15 | ||
| Therapy | |||
| SCIG/IVIG (%)*** | 62/38 | ||
*
Cases include any history of idiopathic thrombocytopenic purpura.
**
Cases include granulomatous disease as confirmed by biopsy.
***
Some patients on IVIG received supplementary SCIG. IVIG: intravenous immunoglobulin therapy; SCIG: subcutaneous immunoglobulin therapy.